Tumour Lysis Syndrome

CE-3 2021 Deadline for Submission: 30 Nov 2021


Cardiovascular and Renal Benefits of SGLT-2 Inhibitors – Is It a Class Effect

CE-2 2021 Deadline for Submission: 31 Jul 2021

Pharmacokinetic drug interaction of protein kinase inhibitors

CE-1 2021 Deadline for Submission: 28 Feb 2021

Pharmacist-led Smoking Cessation: Pharmacological and Non-Pharmacological Options

CE-5 2020


COVID-19: An Overview of its Transmission, Management and Prevention Strategies

CE-4 2020

Medication Management in Patients Undergoing Surgery

CE-3 2020

Review of Neurokinin-1 Receptor Antagonists in Chemotherapy-Induced Nausea and Vomiting

CE-2 2020

Spinal Muscular Atrophy: A Treatment Update

CE-1 2020

Dronedarone: A Review in Atrial Fibrillation

CE-3 2019

Update on Drug Treatments for Idiopathic Pulmonary Fibrosis for Hong Kong Pharmacists


CE-2 2019 Deadline for Submission 31 Mar 2019


Management Approach of Hemophilia A and B


CE-1 2019 Deadline for Submission 31 Mar 2019


Edoxaban - A New Direct Oral Anticoagulant

CE-8 2018 Deadline for Submission 30 Nov 2018

Eteplirsen: A Novel Gene Therapy for Duchenne Muscular Dystrophy


CE-7 2018 Deadline for Submission 30 Nov 2018


Promising new developments in our fight against Drug-resistant Mycobacterium tuberculosis (TB)


CE-6 2018 Deadline for Submission 31 Oct 2018


Review of Newly Registered Anticoagulants and a Reversal Agent for Dabigatran: Bivalirudin, Edoxaban and Idarucizumab


CE-5 2018 Deadline for Submission 30 Sep 2018


Understanding Adverse Drug Reactions and Drug Allergies: a Brief Overview

CE-4 2018 Deadline for Submission 30 Jun 2018

Update on the Safety of Paracetamol

CE-3 2018 Deadline for submission 31 MAR 2018

New Inhaler Devices

CE-2 2018 Deadline for submission 28 Feb 2018

NDM-producing 'Superbugs' and the Treatments options

CE-1 2018 Deadline for submission 28 Feb 2018

Drug-induced Photosensitivity

CE 4-2017  Deadline for submission 31 Dec 2017